Consent for Donation of Tumor Sample, Peripheral Blood and Bone Marrow to Test the Competence of the Immune System — Patient Donors May 5, 2022 By Jesse Bufkin
Assessment of Pulmonary Vasculature and Perfusion Using Dual Energy Radiography and Digital Tomosynthesis of the Chest May 5, 2022 By Jesse Bufkin
Quantification of Lung Fibrosis Using Digital Tomosynthesis and Dual Energy of the Chest May 5, 2022 By Jesse Bufkin
Viral Infections in Immunocompromised and Immunocompetent Individuals: Natural Course, Diagnostic Methods, and Immunologic Responses May 5, 2022 By Jesse Bufkin
Radiosurgery vs. Lobectomy for TemporalLobe Epilepsy (ROSE): A Phase III Clinical Trial May 5, 2022 By Jesse Bufkin
Randomized Phase 2 Study of MLN8237, an Aurora A Kinase Inhibitor, Plus Weekly Paclitaxel or Weekly Paclitaxel Alone in Patients with Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, Preceded by a Phase 1 Portion in Patients wit May 5, 2022 By Jesse Bufkin
A Phase 1 Dose Finding Study of the Safety and Pharmacokinetics of XL184 Administered Orally in Combination with Temozolomide and Radiation Therapy in the First Line Treatment of Subjects with Glioblastoma. XL184-002 May 5, 2022 By Jesse Bufkin
